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A B S T R A C T
Microbes are proliﬁc sources of bioactive molecules; however, the cultivability issue has severely
hampered access to microbial diversity. Novel secondary metabolites from as-yet-unknown or atypical
microorganisms from extreme environments have realistic potential to lead to new drugs with beneﬁts
for human health. Here, we used a novel approach that mimics the natural environment by using a
Miniaturized Culture Chip allowing the isolation of several bacterial strains from Antarctic shallow water
sediments under near natural conditions. A Gram-negative Antarctic bacterium belonging to the genus
Aequorivita was subjected to further analyses. The Aequorivita sp. genome was sequenced and a
bioinformatic approach was applied to identify biosynthetic gene clusters. The extract of the Aequorivita
sp. showed antimicrobial and anthelmintic activity towards Multidrug resistant bacteria and the
nematode Caenorhabditis elegans. This is the ﬁrst multi-approach study exploring the genomics and
biotechnological potential of the genus Aequorivita that is a promising candidate for pharmaceutical
applications.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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The total number of bacterial species in the world is estimated
to vary from 107 to 109 [1], but most of them have never been
cultivated. Culture-independent methods have demonstrated the
enormous richness of biodiversity in the microbial world [2,3], but
this wealth remains largely inaccessible. The “challenge of
uncultivable microorganisms” is a topic that has been concerning
scientists for many years. Solutions to this problem could facilitate
the discovery of new strains holding novel and different features,
which biotechnology could exploit. The problem, which is also
known as the “great plate count anomaly” [4,5] is based on the
observation, that less than 1% of microbes present in an* Corresponding author at: Institute of Protein Biochemistry, National Research
Council, Via P. Castellino, 111 I-80131, Naples, Italy.
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there is a large number of reasons that marine bacteria cannot be
easily cultured in laboratory conditions, the problem can often be
the difﬁculty of replicating the very precise environmental
conditions required for the growth. Free-living microbes can have
a broad array of environmental requirements, for example many
organisms cannot survive in high-nutrient conditions common to
many types of culture media. The development of low-nutrient
media has greatly increased the number of organisms that have
been successfully cultured [6]. An even more serious problem is
that many marine microorganisms have adapted to their low
resource environment by growing very slowly or entering in a
dormant stage, hence it is necessary to ﬁnd the right conditions to
trigger entry into cell replication [6]. Among the strategies for the
isolation and cultivation of new or atypical microorganisms, the
simulation of the natural environment is probably the most
promising. The use of innovative devices that are able to mimic
natural conditions enhances the possibility of cultivating different
microbial species. One of these systems is the Miniaturized Culture
Chip (MCC), which is a disposable array of thousands ofe under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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of the MCC is that it can be placed directly on natural samples (such
as sediments) with nutrients available to the microorganisms via a
porous ceramic that forms the base. This device simulates the
natural habitat, in which microorganisms live in community, and
allows the communication among microorganisms [7–9]. The
isolation of new strains also enables exploration of the chemical
diversity of natural products they synthesize. Microorganisms are
well-known for producing a large variety of antimicrobial agents.
Marine microorganisms are no exception and they have also
proven to be a rich source of potent natural products with
antimicrobial, antiinﬂammatory, antiviral, and anticancer activity
[10]. In particular, the discovery of novel secondary metabolites as
antibiotic lead compounds is urgently needed in order to
counteract the spread of MultiDrug Resistant (MDR) bacteria.
Recently, the World Health Organization [11] published its ﬁrst
ever list of antibiotic-resistant "priority pathogens" – a catalogue of
12 families of bacteria that pose the greatest threat to human
health. The list includes MDR bacteria such as Acinetobacter
baumannii, Pseudomonas aeruginosa and methicillin-resistant
Staphylococcus aureus (MRSA). They are able to provoke recalci-
trant infectious, especially in hospitals where they pose the major
challenge to patient safety, resulting in one of the leading causes of
death in the USA and Europe with high costs for their public health
[12]. The redundancy in the discovery of already known
compounds, generally produced by well-known and repeatedly
isolated species, increases the demand of searching for novel
drugs. In the search of new antibiotics or new molecules of
pharmaceutical interest, the exploration of microorganisms from
extreme environments may lead to the identiﬁcation of strains that
can provide novel types of compounds for biotechnology [13].
Antarctica is one of the most extreme places on Earth. The isolated
and unique Nature of Antarctica, characterized by low temper-
atures, oligotrophic environment, long periods of light/dark, has
drawn the attention of the scientists. Antarctica and the
surrounding oceans represent an untapped area for exploring
biodiversity and potentially unknown organisms adapted to the
extreme living conditions. These extremophiles exhibit physical
and chemical adaptations not found elsewhere on the planet [14].
The genus Aequorivita (family Flavobacteriaceae) was discovered
for the ﬁrst time in 2002 from Antarctic terrestrial and marine
habitats [15]. The members of this genus are Gram-negative, non-
motile, psychrotolerant, strictly aerobic bacteria, producing orange
or yellow pigments. Thus far, the genus Aequorivita has remained
rarely isolated and poorly investigated. Previous studies have
reported the taxonomy, fatty acid composition and DNA G + C
content of A. lipolytica, A. viscosa, A. sublithincola, A. crocea, A.
antarctica and A. capsosiphonis [15]. Herein we report the isolation
of a poorly investigated strain of Aequorivita sp., from Antarctic
shallow water sediments by employing the MCC method, as well as
its whole genome sequencing, the analysis of the biosynthetic gene
clusters and the evaluation of its antimicrobial and anthelmintic
potential. To our knowledge, this is the ﬁrst study exploring the
genus Aequorivita for its bioactivity.
2. Material and Methods
2.1. Collection of Antarctic sediments
Shallow water (50 cm depth) sediments were collected by using
sterile 50 mL Falcon tubes, (Sarstedt) in January 2014, from 3
different sites during an expedition in the framework of National
Program for Antarctic Research of Italy (PNRA) in the area of
Edmonson Point, Antarctica, 74 200 (74.3333) South, 165 80
(165.1333) East. The samples were transported to the laboratory in
dry ice and stored at 80 C until initializing the experiments.2.2. Design, fabrication and preparation of culture chips for the
isolation of microorganisms
MCC was used to isolate microorganisms grown as micro-
colonies [9]. MCC contained arrays of microwells with a Porous
Aluminum Oxide (PAO) base (8  36 mm, 60 mm thick, 40%
porosity, 20 to 200 mm pore diameter) acting as a sterile ﬁlter.
MCC was fabricated by patterning the wall material (Ordyl 300
ﬁlm, Elga, Italy) using photolithography and then applying it to
8  36 mm strips of PAO arrayed on a silicon wafer. Walls were
patterned by photolithography of 10 mm thick Ordyl 300 ﬁlm
according to the manufacturer’s protocols. The resulting
perforated and processed material was heat/pressure applied
to the PAO. Platinum (10 nm) was used to sputter coat the upper
surface of the MCC. Wells had 180 mm diameter, spaced 160 mm
in a hexagonal patterning with 4500 microwells per chip. MCC
was sterilized using a high-intensity UV ozone cleaner (PSD,
Novascan, USA) for 15 min. It is basically a high number of
miniaturized Petri dishes on a chip containing wells which can
host one or more microbes. On the bottom of the chip there is a
ﬁlter of 0.22 mm which circumvents the passage of the microbes
through the chip. So, it can be placed directly on sediments or on
a ﬂat surface and inoculated with the sample [7]. For this
experiment, two different growth conditions were used in order
to evaluate the effect of different nutrients on the microbial
growth. Condition A, minimal: sediment was packed into a Petri
dish and overlaid with a thin layer of agarose 1% (w/v) mixed
with a ﬁltered solution of 0.001% (w/v) FeSO4  7H2O. Condition
B, richer: sediment was packed into a Petri dish and overlaid
with a thin layer of agarose 1% (w/v) mixed with a ﬁltered
solution of 0.001% (w/v) FeSO4  7H2O, 3% (w/v) Sea Salt, 1 g/L
Peptone, 0.5 g/L Yeast Extract. Sterile cultivation chips were
placed on the solidiﬁed mixture composed by sediments,
nutrients and agarose. Then, 0.5 g of Antarctic sediments (same
sediments within the chip) were dissolved in 1 mL of sterile
water, shaken by using a vortex and subjected to 10-fold serial
dilutions until the dilution 105. Three mL of each dilution was
gently spread-plated on the chip by using a 1 mL sterile plastic
loop. Finally, not all the wells will contain microorganisms. After
10 and 45 days of incubation at 7 C the recovery of micro-
colonies from wells was carried out using a ﬁne sterile toothpick
using a dissection microscope to visualize the target microcolony
(see Fig. 1). Finally, picked microcolonies were dissolved in
sterile water. Half of the sample was used to perform the
identiﬁcation, while the other half was stored at 80 C with 20%
(v/v) glycerol.
2.3. Molecular identiﬁcation and phylogenetic analysis of isolated
strains
The phylogenetic afﬁliation of bacterial isolates was per-
formed through the 16S rRNA genes ampliﬁcation and analysis.
The freeze and thaw method was used to obtain bacterial
genomic DNA. In particular, a colony of each isolate was picked,
dissolved in 100 mL of sterile water, transferred in 0.5 mL
Eppendorf-tube, mixed with a shaker and frozen at -20 C for
minimum 1 h. Thereafter, the frozen tubes were incubated for
15 min at 99 C in a thermocycler, centrifuged for 10 min at
8900 rpm and then 50 mL of supernatant was transferred in a
new 0.5 mL Eppendorf-tube and used as template for the
ampliﬁcation via PCR of 16S rDNA genes. PCR was carried out
in a total volume of 50 mL containing DreamTaq PCR Master Mix
(a ready-to-use solution containing DreamTaq DNA Polymerase,
optimized DreamTaq buffer, MgCl2, and dNTPs) and 1 mM of
primer Eub27 F (Forward, seq: 50-AGAGTTTGATCCTGGCTCAG-30)
Fig. 1. MCC180.10 culture chip picture (A). Microscope view of the MCC180.10 (B). Bacterial colonies visible on the chip after 7 days of incubation (C). The scale bar in (A)
indicates 4 mm when applied to (A) 200 mm when applied to (B) and 360 mm when applied to (C).
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[16]. The reaction conditions used were: one cycle (93 C for
2 min), 30 cycles (92 C for 30 s, 55 C for 30 s, and 72 C for
1 min), with a ﬁnal extension of 5 min at 72 C. PCR products
were then puriﬁed and sequenced by Institut für Klinische
Molekularbiologie (IKMB), Kiel University, and submitted to
BLAST for the phylogenetic afﬁliation. The strain identiﬁed as
Aequorivita sp. was selected for further studies and the 16S rRNA
gene sequence was deposited in GenBank (accession number
MH012204). MEGA7 software [17] was used to align the sequences
and to construct the phylogenetic tree. The evolutionary history
was inferred using the Neighbor-Joining method.
2.4. Genome sequencing of Aequorivita sp.
The whole genome of Aequorivita sp., and other two Aequorivita
strains (stored at Biological Resource Center of Institut Pasteur) A.
lipolytica CIP 107455T, and A. antarctica CIP 107457T was obtained
using the Wizard1 Genomic DNA Puriﬁcation Kit (PROMEGA,
USA). The whole genome sequencing was carried out at the
Mutualized Microbiology Platform (P2M) of the Pasteur Interna-
tional Bioresources network (PIBnet) of the Institut Pasteur, Paris,
France, using the Nextera XT DNA sample preparation kit (Illumina,
USA) for 2  150-bp paired-end sequencing as per the manufac-
turer’s instructions. All sequenced paired-ends reads were clipped
and trimmed with AlienTrimme [18], corrected with Musket [19],
merged (if needed) with FLASH [20], and subjected to a digital
normalization procedure with khmer [21]. For each sample,
remaining processed reads were assembled and scaffolded with
SPAdes [22]. Genomes were analyzed using the anti-SMASH 3.0
web server (http://antismash.secondarymetabolites.org) and the
biosynthetic gene clusters were identiﬁed. The newly isolated
Aequorivita sp. strain was deposited in the Collection of Institut
Pasteur (CIP), France, under accession number CIP 111184.
Moreover, the three genomes were deposited in European
Nucleotide Archive (ENA) with codes: Aequorivita sp.GCA_900489465.1, A. lipolytica GCA_900489485.1 and A. antarctica
GCA_900489835.1.
2.5. Cultivation and extract preparation
A single colony of a bacterial isolate was used to inoculate 3 mL
of liquid Marine Broth (MB, DifcoTM) medium in sterile bacterio-
logical tubes. After 48 h of incubation at 20 C at 200 rpm, the
culture was used to inoculate 125 mL of MB medium in a 500-mL
ﬂask, at an initial cell concentration of 0.01 OD600/mL. The ﬂasks
were incubated up to ﬁve days at 20 C at 200 rpm. The cultures
were then centrifuged at 6000 rpm at 4 C for 30 min. Then, the
exhausted culture broth and the pellet were collected and
subjected to extraction with ethyl acetate separately, yielding
the extracellular and intracellular extracts, respectively. Brieﬂy, the
exhausted culture broths (125 mL) were subjected to organic
extraction using ethyl acetate (3 x 125 mL, ratio 1:1) in a 500 mL
separatory funnel. The organic phase collected was evaporated to
dryness using a Laborota 4000 rotary evaporator (Heidolph,
Schwabach, Germany) affording the extracellular extract. The
pellet was mechanically disrupted using an Ultraturrax for 5 min at
10,000 rpm and then extracted by ethyl acetate as described for the
exhausted broth, providing the intracellular extract. The dried
extracts were weighed, dissolved in 100% DMSO at the ﬁnal
concentration of 50 mg/mL and stored at -20 C.
2.6. Pathogenic bacteria growth conditions
The following multidrug-resistant strains of human pathogens
were used in this work: Pseudomonas aeruginosa DSM 50071,
Staphylococcus aureus DSM 346, methicillin-resistant Staphylococ-
cus aureus (MRSA) DSM 18827, Acinetobacter baumannii DSM
300007 Klebsiella pneumonia DSM 30104 (Leibniz Institute DSMZ-
German Collection of Microorganisms and Cell Cultures, Braunsch-
weig, Germany). The strains were routinely grown at 37 C in Luria
Bertani medium (10 g/L Tryptone, 5 g/L Yeast extract, 10 g/L NaCl) at
200 rpm.
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To evaluate the antimicrobial potential of the Aequorivita sp.
extracts, samples were placed into a 96-well microtiter plate at
initial concentration of 1000 mg/mL. Then it was serially diluted
using LB medium (2-fold dilution). The ﬁnal extracts concentration
was 500, 250, 120, 60, 30, 15 mg/mL. A single colony of selected
pathogen strains, P. aeruginosa DSM 50071, S. aureus DSM 346,
MRSA DSM 18827, A. baumannii DSM 300007 and K. pneumoniae
DSM 30104 was used to inoculate 3 mL of liquid LB medium in
sterile bacteriological tube. DMSO was used as negative control
and 25 mM Doxycycline for A. baumannii DSM, 6 mM Chloram-
phenicol + 25 mM Penicillin for MRSA, 50 mM Chloramphenicol for
P. aeruginosa and K. pneumoniae as positive control. After 6-8 h of
incubation, growth was measured by monitoring the absorbance
at 600 nm and about 0.04 OD/mL in 100 mL were dispensed in each
well of the prepared plate reaching a ﬁnal volume of 200 mL. Plates
were incubated at 37 C for 24 h and growth was measured with a
Tecan plate reader by monitoring the absorbance at 600 nm.
Values of bioactivity are reported in IC50, the half maximal
inhibitory concentration, which is a measure of the potency of a
substance in inhibiting a speciﬁc biological or biochemical
function. In this case IC50 is used to describe the antimicrobial
effect of a crude extract.
2.8. Anthelmintic activity
In order to test the effect of the crude extracts on C. elegans
Wild-type (WT) Bristol N2 obtained from the Caenorhabditis
Genetic Centre (CGC), a liquid toxicity assay has been set-up [23].
The assay was performed in 24-well plates. Each well contained a
400 mL solution of M9 buffer, 5 mg/mL cholesterol, and Escherichia
coli OP50 at the concentration of 0.5 OD/mL as nutrient source [24].
The intracellular extract of Aequorivita sp. was then added at
different concentrations, 500, 250, 120, 60, 30, 15 mg/mL to each
well. C. elegans was synchronized by bleaching treatment [25], and
30–40 L4 worms were transferred to each well and incubated at
20 C up to seven days. The wells were scored for living worms
every 24 h. A worm was considered dead when it no longer
responded to touch. For statistical purposes, 3 replicates per trial
were carried out with a unique egg preparation.1% (v/v) DMSO was
used as negative control.
2.9. Cell viability assay (MTS assay)
The assay to determine cell survival was conducted by using
HFFF2 (ECACC 86031405) cells as target and the MTS (3-(4,5-
Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfo-
phenyl)-2H-tetrazolium) as tetrazolium compound to determine
the number of viable cells. Cells were seeded at 7.5 103 cells/well
in a sterile 96-well microtiter plate and allowed to adhere
overnight by growing at 37 C and 5% CO2. The various concen-
trations of Aequorivita sp. intracellular extracts (30, 62, 125, 250,
500 mg/mL) were added. DMSO, the solvent used to dissolve the
extracts served as negative control. Three replicate wells were used
per concentration. The treated cells were then incubated for 24 h at
37 C and 5% CO2. After incubation, the medium was removed and a
mixture consisting of 100 ml of fresh medium and 20 mL of reagent
(MTS:Phenazine MethoSulfate 19:1) was added in each well. The
plate was again incubated for 1 h at 37 C and 5% CO2 in the dark to
allow the reduction of MTS into a colored formazan product by
living cells. In order to quantify the amount of formazan produced,
directly proportional to the number of living cells after extracts
treatment, absorbance was measured at 490 nm, using an ELISA
plate reader.3. Results
3.1. Isolation of Antarctic microorganisms using MCC
MCCs were used to isolate Antarctic bacteria from shallow
water sediments. Two different conditions were used: one
minimal, containing the Antarctic sediments as only nutrient
source and the other richer, composed by sediments, peptone,
yeast extract and sea salt were tested. After 10 days at 7 C, the ﬁrst
colonies appeared, but the chip was kept in incubation up to 45
days, allowing the formation of slow-growing strains (Fig. 1). A
total of 19 colonies were visualized by microscope and collected.
The minimal and richer conditions showed similar numbers of
colonies, 9 and 10 colonies respectively, and genera distribution
indicating that natural sediments could contain a sufﬁcient
amount of nutrients to allow the microbial growth.
3.2. Identiﬁcation of bacterial isolates
The molecular analysis showed a prevalence of Pseudomonas sp.
(9 strains), an equal number of Shewanella sp. and Psychrobacter sp.
(4 strains), one Algoriphagus sp. and one Aequorivita sp. This last
strain, showing 98% of identity with Aequorivita antarctica and 96%
of identity with Aequorivita sublithincola, was obtained from the
minimal condition and selected for further experiments because of
the lack of previous studies about the bioactivity displayed by
Aequorivita genus. A phylogenetic tree was built and the results are
shown in Fig. 2.
3.3. Genomics of Aequorivita sp
Due to the lack of information on the genus Aequorivita, the
whole genome’s of Aequorivita sp., A. lipolytica CIP 107455T and A.
antarctica CIP 107457T strains were sequenced and subjected to a
genome mining approach in order to identify the presence of
biosynthetic gene clusters (BGCs). The whole genome of Aequor-
ivita sp. has a total length of 3.5 Mb and was deposited in the
European Nucleotide Archive (ENA). The antibiotics and
Secondary Metabolite Analysis Shell (anti-SMASH) has served as
a comprehensive web server and a stand-alone tool for the
automatic genomic identiﬁcation and analysis of BGCs,
facilitating rapid genome mining of a wide range of bacterial
and fungal strains. Using the anti-SMASH 3.0 web server, it is
possible to compare identiﬁed BGCs with those encoding the
biosynthetic pathways for known compounds from the “Minimum
Information about a Biosynthetic Gene cluster” (MIBiG) commu-
nity project (http://mibig.secondarymetabolites.org/) [26]. The
gene cluster identiﬁcation algorithms in tools such as anti-SMASH
is based on the detection of one or more conserved protein
domains using curated models; certain protein domains or
domain combinations are indicative of biochemical functions that
are speciﬁc to certain biosynthetic pathways; hence they can be
used as “signatures” to identify certain classes of BGCs [27]. The
cluster arylpolyene-resorcinol, similar to the ﬂexirubin biosyn-
thetic gene cluster and the arylpolyenes (APE) biosynthetic gene
cluster, were found in the genome of Aequorivita sp. as well as in
the genome of the A. antarctica CIP 107457T and A. lipolytica CIP
107455T (Table 1). Different saccharide clusters were detected in
all Aequorivita strains, mainly a cluster similar to the capsular
polysaccharide biosynthetic gene. Furthermore, in the genome of
Aequorivita sp. strain a gene with 69% of identity with the Type III
polyketide synthase of Zobellia galactanivorans was detected in the
gene cluster T3pks-arylpolyene (data not shown). An NRP/
Polyketide cluster was detected in the A. lipolytica CIP 107455T
strain (Table 1).
Table 2
Antimicrobial activity of Aequorivita sp. intracellular and extracellular extracts
against a panel of MDR bacteria. Positive control has been performed using
antibiotics: Doxycycline, Chloramphenicol and Penicillin. Bacterial growth was
measured in OD600/mL.
IC50 value
Strain Intracellular Extracellular Positive control
P. aeruginosa 500 mg/mL No inhibition 50 mM Chl
MRSA 120 mg/mL No inhibition 6 mM Chl + 25 mM Pe
A. baumannii 250 mg/mL No inhibition 25 mM Dox
K. pneumoniae No inhibition No inhibition 50 mM Chl
Fig. 2. Evolutionary relationships of taxa and showing the placement of Aequorivita sp. (23 L) isolate. The evolutionary history was inferred using the Neighbor-Joining
method. The optimal tree with the sum of branch length = 0.58717318 is shown. The percentage of replicate trees in which the associated taxa clustered together in the
bootstrap test (1000 replicates) are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to
infer the phylogenetic tree. The evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of the number of base
substitutions per site. The analysis involved 19 nucleotide sequences.
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In order to test the capability of the new isolate to produce
antimicrobial compounds, intracellular and extracellular extracts
from the Aequorivita sp. culture were generated. The bacterium
was grown for ﬁve days in MB, producing a very strong yellow
pigment. Results showed in Table 2 demonstrated that extracellu-
lar extract is totally inactive, while the intracellular extract shows
an antimicrobial effect against three out of four-target pathogens.
In particular, the most promising activity was detected against
MRSA (IC50 value of 125 mg/mL), the only Gram-negative tested.
Increasing the extract concentration, an inhibition effect wasTable 1
Biosynthetic gene clusters (BGCs) in the Aequorivita sp. whole genome compared with two Aequorivita type strains: A. antarctica CIP 107457T and A. lypolitica CIP 107455T)
using the anti-SMASH 3.0 web server (http://antismash.secondarymetabolites.org).
Gene Cluster Type MIBiG BGC-ID Most similar known cluster Aequorivita
sp.
Aequorivita
antarctica CIP
107,457 T
Aequorivita
lipolytica CIP
107,455 T
Cf_saccharide Saccharide BGC0000733_c1 Capsular polysaccharide biosynthetic gene cluster X X X
Cf_saccharide Saccharide BGC0000773_c1 Lipopolysaccharide biosynthetic gene cluster; O-antigen
biosynthetic gene cluster
X – –
Arylpolyene-
Resorcinol
Polyketide BGC0000838_c1 Flexirubin biosynthetic gene cluster; Aryl polyene (APE)
biosynthetic gene cluster
X X X
Cf_saccharide Saccharide BGC0000766_c1 Exopolysaccharide biosynthetic gene cluster – X X
Cf_saccharide Saccharide BGC0000781_c1 O-antigen biosynthetic gene cluster X – –
Cf_saccharide Saccharide BGC0000791_c1 O-antigen biosynthetic gene cluster; Lipopolysaccharide
biosynthetic gene cluster; Exopolysaccharide biosynthetic gene
cluster
X – –
Cf_saccharide Saccharide BGC0000799_c1 Colanic acid biosynthetic gene cluster – X –
Cf_saccharide NRP /
Polyketide
BGC0000960_c1 Azinomycin B biosynthetic gene cluster – – X
Fig. 4. Cell viability assay using HFFF2 cells in presence of Aequorivita sp.
intracellular extract (Light grey bars). Values are reported as percentage of surviving
cells. DMSO plus HFFF2 cells and HFFF2 alone were used as controls.
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aeruginosa (IC50 value of 500 mg/mL). No effect was detected
against K. pneumoniae. The extracts at 60, 30 and 15 mg/mL are not
shown in the ﬁgures and tables.
3.5. Anthelmintic activity of Aequorivita sp. crude extracts
Both intra and extracellular crude extracts were also tested for
their ability to kill nematodes using C. elegans as model system.
Again, only the intracellular extract had signiﬁcant in vitro
anthelmintic effect after 3 days of incubation. The intracellular
extract was able to kill 90% of worms at the concentration of
500 mg/mL, 80% and 60% at respective concentrations of 250 mg/
mL 120 mg/mL as showed in Fig. 3. The extracts at 60, 30 and 15 mg/
mL are not shown in the ﬁgures and tables.
3.6. Evaluation of Aequorivita sp. extract toxicity
Cell viability assays were carried out by using human
ﬁbroblastic cells HFFF2 (ECACC 86031405) that represent a model
system of skin cells. The value of percentage of viable cells after the
treatment was obtained by normalizing the value of absorbance in
each well with the correspondent value of absorbance of DMSO, at
the same concentration. Only the intracellular extract was
evaluated for its toxicity. Results demonstrated that the crude
extract has no toxic effect against HFFF2 cells (Fig. 4) even at the
highest tested concentration 500 mg/mL, which is the concentra-
tion that always showed antimicrobial and anthelmintic activity.
Results are shown as percentage of viable cells after the treatment
at different concentration of sample.
4. Discussion
Microbes have been a major source of natural antibiotics
playing a very signiﬁcant role in historical and modern antibiotic
drug discovery [28]. However, these efforts are seriously hampered
by their limited cultivability in artiﬁcial laboratory conditions
because most of them don’t grow when extrapolated from their
natural environment [29]. Hence different strategies are manda-
tory for successful isolation and cultivation of strains from new,
untapped environments. In this work, we have isolated several
microorganisms from an extreme environment, Antarctica, by
using a Miniaturized Culture Chip (MCC) [7]. The main idea of MCC
is the simulation of natural environment, by laying the chipFig. 3. Anthelmintic activity of Aequorivita sp. extracellular (Black bars) and
intracellular extracts (Light grey bars). Activity is expressed as the percentage of
surviving worms after 3 days of incubation in the presence of extracts. DMSO plus
worms and OP50 plus worms were used as controls.directly on natural sediments that become the only substrate for
the growth of microorganisms. By the diffusion of nutrients
obtained from sediments and by stimuli received from the
bacterial community present in it, microbes can grow on the
top of the chip as microcolonies. They are partially protected by the
overgrowth of the neighbouring microbes but available for
imaging and recovery. A similar idea forms the basis of the iCHIP,
developed by Lewis and Epstein [30], that is composed by
microwells and semipermeable membranes. The use of iCHIP
allowed Ling et al., to isolate a new β-proteobacteria provisionally
named Eleftheria terrae able to produce a new antibiotic molecule,
teixobactin [31]. The choice for studying Antarctic sediments as a
source of new strains is due to the fact that Antarctica is a unique
habitat. It is one of the most hostile places on Earth, characterized
by low temperatures and other extreme traits, such as long light/
dark period and poor nutrient levels. Such extreme conditions
would be expected to shape the evolution and adaptation of both
primary and secondary metabolism of the Antarctic bacteria, to
lead to the production of chemical molecules with unique
functions [32]. Moreover, a survey conducted by the international
Census of Marine Life demonstrated the high biodiversity of this
extreme habitat and the marine environment around it [33]. In this
study, the application of the MCC to Antarctic sediments led to the
isolation of different genera of bacteria. Two nutritional conditions
(A minimal; B richer) were applied in order to see some changes in
the microbial community. In particular, from the chip, bacteria
belonging to the genus Pseudomonas sp., Shewanella sp. and
Psychrobacter sp. together with an Algoriphagus sp. and an
Aequorivita strain have been retrieved. Genera like Pseudomonas,
Shewanella and Psychrobacter include many different species and
are commonly retrieved from a wide range of marine environ-
ments meaning that their genetic and metabolic potential is highly
versatile. One example is represented by Shewanella violacea, a
violet gram-negative bacterium isolated from marine sediment in
the Ryukyu Trench at a depth of 5110 m [34]. In this work, a similar
number of colonies were observed on the two nutritional
conditions without any signiﬁcant variation in the strain distribu-
tion. This could indicate that bacteria used natural sediments as
primary nutrient source for the growth, highlighting the impor-
tance of the reproduced microenvironment for bacterial survival.
The diffusion of nutrients from sediments, the communication
among microorganisms up and down the MCC, the protection of
slower growing strains by overgrowth of more aggressive or
rapidly growing strains by the MCC wells, could be all be important
factors that allowed the cultivation of microorganisms. As
F. Palma Esposito et al. / Biotechnology Reports xxx (2018) e00281 7conﬁrmed by Pulschen et al., who was able to isolate several
previously uncultured Antarctic strains, long incubation period
and low nutritional media are still useful and effective approach for
the isolation of rare/novel microorganisms [35]. Several strains
belonging to the genus Aequorivita have been isolated from
Antarctica (sea water, ice, algae, stones) but few studies about
these bacteria were performed such as taxonomy, nutrients
requirements, growth conditions, DNA G + C content, fatty acid
composition [15]. The lack of any previous study evaluating the
bioactive potential of this genus makes this strain a good candidate
for further studies. The whole genome sequencing of Aequorivita
sp. and its analysis by anti-SMASH indicated the presence of
several BGCs. BGCs have been described for hundreds of bacterial
metabolites and even though they can be accurately identiﬁed and
quantiﬁed, the question still remains, which of these are most
likely to encode the production of potent antimicrobials. The most
prominent family of BGCs already described includes two
subfamilies distributed throughout the Proteobacteria; their
products are aryl polyenes (APEs) [36] also found in Aequorivita
sp. and in other strains. Although these clusters are widely
divergent in sequence, their small molecules are remarkably
conserved, suggesting the important role that these compounds
play in Gram-negative cell biology. The APEs are structurally
similar to ﬂexirubin, a pigment that was previously isolated from
Flexibacter elegans [37]. A role for APEs in protecting Gram-
negative bacteria against oxidative stress makes them analogous to
the chemically similar Gram-positive carotenoids [36] although
they are biosynthetically distinct. The strong yellow/orange
Aequorivita sp. pigmentation could suggest the production of
these molecules, so future studies, aimed at the evaluation/
selection of the best growth condition for the expression of
antioxidant compounds, will be performed. In addition, numerous
gene clusters encoding genes for saccharides were found. Cell-
associated saccharides, such as lipopolysaccharides and capsular
polysaccharides are known to play key roles in microbe-host and
microbe-microbe interactions, while diffusible saccharides have a
range of biological activities, most notably antibacterial [38,39].
Non-ribosomal peptides (NRPs) are the major multi-modular
enzyme complex which synthesizes secondary metabolites in
bacteria and fungi. In the genome of Aequorivita sp. a gene with 69%
of identity with the Type III polyketide synthase of Zobellia
galactanivorans was detected in the gene cluster T3pks-arylpo-
lyene (data not shown), indicating a possible role of this cluster in
the production of polyketides. The lack of any data on bioactive
potential of Aequorivita genus motivated for the cultivation of the
isolated Aequorivita sp. strain and the evaluation of antimicrobial
and anthelmintic activity of its extracellular and intracellular
extract. Analysis of the antimicrobial potential of this bacterium
revealed a promising inhibitory activity against some pathogenic
MDR bacteria. In particular, the intracellular crude extract of
Aequorivita sp. (obtained by mechanical disruption of bacterial
cells followed by organic extraction) showed promising antimi-
crobial effect against MRSA, the causative agents of serious
hospital infections. Vancomycin and linezolid have become the
only drugs to counteract the MRSA infections, however, treatment
failures, adverse side effects and the early developed resistance
highlight the necessity of alternative therapies [40]. The lack of
new antibiotic molecules entering the market and the overuse/
misuse of the existing antibiotics are generating an alarming
situation for human health. This phenomenon involves not only
infections caused by MDR bacteria but also helminth infections.
Millions of people are affected by helminth infections each year
and new anthelmintic agents are urgently needed to treat and
control these diseases [41]. In this study, we have shown
Aequorivita sp. intracellular extract to be active, without toxic
effects on HFFF2 cells, towards the nematode C. elegans, a modelsystem used to in screening of anthelmintic drugs. Considering
that the bioactivity was evaluated using crude extracts, the
antimicrobial activity may increase after several puriﬁcation step
of the extract. The fact that both antimicrobial and anthelmintic
activities are expressed by the intracellular extract is not
surprising. Most of antimicrobials are expressed outside the cell
for cell defense but the intracellular nature of some antimicrobial
compounds is not unusual, although their ecological role is still not
clear [42,43]. They could be involved in intracellular signalling or
have a defensive role [44]. A bioassay-guided puriﬁcation strategy
should lead to the identiﬁcation of natural compounds responsible
for the bioactivity and further studies will be necessary to fully
understand the mechanisms of action of the identiﬁed molecules.
In particular, the scale-up of the culture will allow obtaining a
sufﬁcient amount of crude intracellular extract for the putiﬁcation,
by using Solid Phase Extraction column and HPLC. Finally, High
Resolution Mass Spectrometry and Nuclear Magnetic Resonance
will be used to identify the structure of the bioactive compounds.
Moreover, the implementation of genomics techniques could guide
the cultivation of this strain in different conditions inducing the
expression of the BGCs present in the genome of Aequorivita sp.
5. Conclusions
In this work a novel isolation method using a Miniaturized
Culture Chip (MCC) allowed the isolation of an unstudied Antarctic
bacterium belonging to the genus Aequorivita. The analysis of the
bioactive potential of the intracellular and extracellular extracts of
this strain showed a promising antimicrobial and anthelmintic
activity. This is the ﬁrst multi-approach study on the genus
Aequorivita involving the isolation by MCC, the analysis of BGCs,
and the evaluation of the bioactivity.
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